Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 29: 543-545, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yatscoff, R. W.
Right arrow Articles by Warnock, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yatscoff, R. W.
Right arrow Articles by Warnock, L. M.

Clinical Chemistry, Vol 29, 543-545, Copyright © 1983 by American Association for Clinical Chemistry

Interference of fetal hemoglobin and labile glycosylated hemoglobin with measurements of glycosylated hemoglobin

RW Yatscoff, GJ Tevaarwerk, CL Clarson and LM Warnock

We examined the effect of fetal hemoglobin and labile glycosylated hemoglobin on a number of diverse methods used to measure glycosylated hemoglobin. Samples were supplemented with various amounts of cord blood to give proportions of fetal hemoglobin ranging from 1 to 20% of total hemoglobin concentration. Procedures in which the separation of hemoglobin A1 from the major hemoglobin A fraction is based on differences in ionic properties (cation-exchange chromatography and electrophoresis) are subject to interference by fetal hemoglobin, whereas procedures that base the quantitation on other properties (colorimetry and affinity column chromatography) are not. The same procedures that are affected by the presence of fetal hemoglobin are also subject to interference by labile glycosylated hemoglobin. We conclude that the affinity chromatographic and colorimetric methods may give a more nearly accurate determination of glycosylated hemoglobin.


The following articles in journals at HighWire Press have cited this article:


Home page
BMJHome page
S Bulusu
Variant haemoglobin may affect measurements
BMJ, March 18, 1995; 310(6981): 740b - 740.
[Full Text]


Home page
BMJHome page
E S Kilpatrick, A G Rumley, M H Dominiczak, and M Small
Glycated haemoglobin values: problems in assessing blood glucose control in diabetes mellitus
BMJ, October 15, 1994; 309(6960): 983 - 986.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.